CHRISTEENA BROWN: Open Payments
NPI 1164963963 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 37 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $167 |
| Lilly USA, LLC | 5 | $101 |
| Eisai Inc. | 5 | $98 |
| Biogen, Inc. | 5 | $93 |
| PFIZER INC. | 2 | $40 |
| Neurelis, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
Products named: KISUNLA, Leqembi, QULIPTA, TYSABRI, UBRELVY, NURTEC ODT, VALTOCO, KESIMPTA.
Industry payments across MD — which companies pay providers there.
